St. Louis Clinical Trials, LLC
Saint Louis, Missouri 63141
We've found
9 trials
at this facility
Schizophrenia Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Updated: 12/31/1969
Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Schizophrenia Clinical Trial
Updated: 12/31/1969
A Study of Paliperidone Palmitate 6-Month Formulation
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Major Depressive Disorder Clinical Trial
Updated: 12/31/1969
A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Psychiatry / Psychology Clinical Trial
Updated: 8/30/2017
Structured Discontinuation vs Continued Therapy in Suboptimal and Optimal Responders to High-dose Long-term Opioids for Chronic Pain
Status: Enrolling,
Phase
IV
Updated: 8/30/2017
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Bipolar I Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Treatment Resistant Depression Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg Daily and 50 mg Daily of REL-1017 in Major Depressive Disorder
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Updated: 12/31/1969
Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials